ILAE-Latin America
Latest News
About ILAE
Large international study discovers 11 new epilepsy genes
A large study to find new epilepsy genes was undertaken by more than 150 researchers from multiple centres in the UK, Europe, USA, Brazil, Hong Kong and Australia as part of the International League Against Epilepsy Consortium on Complex Epilepsies. The results tripled the number of known genetic associations for epilepsy and importantly implicated 11 new genes.
10 December, 2018
Clinical Research
Antiepileptic drug treatment after an unprovoked first seizure: A decision analysis
Our model determined that immediate AED treatment is preferable to deferred treatment in adult first-seizure patients over a wide and clinically relevant range of variables. Furthermore, our analysis suggests that the 10-year seizure recurrence rate that justifies AED treatment (38.0%) is substantially lower than the 60% threshold used in the current definition of epilepsy.
9 October, 2018
About ILAE
Marco Medina awarded Chevalier de la Légion d'Honneur
On September 3rd, 2018 the French President, Emmanuel Macron, nominated Marco Medina as Chevalier de la Légion d´Honneur, the highest French order of merit for military and civil merits.
8 October, 2018
About ILAE
Neonatal Seizure Classification
The ILAE Task Force on Neonatal Seizures has created a classification for seizures in the neonate, which is intended to become the ILAE position on the classification for seizures in this age group. As part of the approval and adoption process the League asks its members to review and comment on…
16 August, 2018
About ILAE
Spotlight on the Colombian Chapter of the ILAE
La Liga Colombiana contra la Epilepsia (LCE), capítulo para Colombia de la ILAE, nació en 1964, en la ciudad de Cartagena de Indias, junto al mar Caribe. Se extendió luego a todo el país. Desde su comienzo tuvo el impulso de trabajar globalmente con los aspectos médicos y psicosociales de las…
30 July, 2018
Subscribe to the ILAE Newsletter
To subscribe, please click on the button below.